Cargando…

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database

PURPOSE: In Switzerland 167 drugs on the market contain information about pharmacogenetics in their drug label (PGx drug). Preemptive pharmacogenetic testing is reimbursed by health care insurance for only seven drugs (abacavir, carbamazepine, 6-mercaptopurine, azathioprine, 5-fluorouracil, capecita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wittwer, Nina L, Meier, Christoph R, Huber, Carola A, Meyer zu Schwabedissen, Henriette E, Allemann, Samuel, Schneider, Cornelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701506/ https://www.ncbi.nlm.nih.gov/pubmed/36447837 http://dx.doi.org/10.2147/PGPM.S382214

Ejemplares similares

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy
por: Wiss, Florine M., et al.
Publicado: (2023)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
por: Stäuble, Céline K., et al.
Publicado: (2021)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022)

Development of the Swiss Database for dosing medicinal products in pediatrics
por: Tilen, Romy, et al.
Publicado: (2021)

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
por: Stäuble, Céline K., et al.
Publicado: (2022)

Pharmacogenetic information in Swiss drug labels – a systematic analysis
por: Jeiziner, C., et al.
Publicado: (2020)

Pharmacogenetic testing in the Veterans Health Administration: Policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
por: Vassy, Jason L., et al.
Publicado: (2018)

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2017)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications
por: Schäfer, Anima M., et al.
Publicado: (2021)

The provision of out-of-hours care and associated costs in an urban area of Switzerland: a cost description study
por: Eichler, Klaus, et al.
Publicado: (2010)

PharmGED: Pharmacogenetic Effect Database
por: Zheng, C. J., et al.
Publicado: (2007)

Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?
por: Oelofse, Carola, et al.
Publicado: (2023)

Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
por: Huber, Carola A, et al.
Publicado: (2016)

Clinical relevance of St. John's wort drug interactions revisited
por: Nicolussi, Simon, et al.
Publicado: (2020)

Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4‐methylaminoantipyrine
por: Bachmann, Fabio, et al.
Publicado: (2021)

Actionable Pharmacogenetic Variation in the Slovenian Genomic Database
por: Hočevar, Keli, et al.
Publicado: (2019)

Physicians’ Opinion Regarding Extended Access to Hormonal Contraception in Switzerland
por: Yous, Tamara, et al.
Publicado: (2021)

Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report
por: Meyer zu Schwabedissen, Henriette E, et al.
Publicado: (2014)

PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism
por: Ehrsam, Daniel, et al.
Publicado: (2019)

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogenetics
por: Grover, Sandeep, et al.
Publicado: (2011)

United States Emergency Department Use of Medications with Pharmacogenetic Recommendations
por: Limkakeng, Alexander T., et al.
Publicado: (2021)

Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta
por: Taggi, Valerio, et al.
Publicado: (2022)

Various effects of repeated rifampin dosing on coproporphyrin levels in humans
por: Kinzi, Jonny, et al.
Publicado: (2023)

Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
por: Begré, Ursina B. M., et al.
Publicado: (2022)

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals
por: Schmid, Yasmin, et al.
Publicado: (2016)

Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2
por: Bachmann, Fabio, et al.
Publicado: (2021)

Issues around the Prescription of Half Tablets in Northern Switzerland: The Irrational Case of Quetiapine
por: Allemann, Samuel S., et al.
Publicado: (2015)

Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources
por: Shugg, Tyler, et al.
Publicado: (2020)

Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011
por: Huber, Carola A, et al.
Publicado: (2014)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_slsami5ips0pi3pb1u7472u0nf